Six companies show interest in vaccine production in Denmark

On Wednesday, six companies were interested in participating in the market consultation held by the Danish State Serum Institute before the tender for Danish vaccination production is settled.

BY ULRICH QUISTGAARD, TRANSLATED BY NIELSINE NIELSEN

Published: 14.05.21 at 15:32

The opportunity to produce covid-19 vaccines in Denmark has attracted the attention of six companies.

The deadline for participating in the Danish State Serum Institute's (SSI) market consultation has now passed, states the SSI's Vice President Ole Jensen in an email to MedWatch.

Already a subscriber? Log in.

Read the whole article

Get 14 days free access.
No credit card required.

Access all locked articles
Receive our daily newsletters
Access our app

Start a free company trial today

"Real world" patient data documents the long-term effects of ALK vaccines

Data from ALK's React study, which is a retrospective real-world evidence study including more than 92,000 patients with respiratory allergies, have just been published in the journal The Lancet Regional Health – Europe. | Foto: ALK / PR

In the largest study ever of its kind, patient data from the "real world" documents the long-term effects of up to nine years of ALK vaccines. Up until now, it has not been possible to demonstrate these in ordinary clinical studies where the follow-up period is shorter, and the new knowledge could be a turning point in ALK's dialog about prices and subsidies with authorities and payers.